In some applications, fragments are more advantageous than intact antibodies. This topic was recently written by Nelson. One of the advantages is that the fragment is smaller than the intact antibody, and can enter the tissue in which the intact antibody cannot enter and exert therapeutic effects and immunohistochemical staining. Antibody fragments are smaller than conventional antibodies and are generally not glycosylated, allowing their products to be expressed in prokaryotic expression systems, saving time and money. However, fragments lacking the Fc domain are faster in vivo than conventional antibodies and are unable to elicit Fc-mediated cytotoxicity unless they bind to a valid original for better therapeutic purposes. However, the lack of an Fc domain is advantageous for immunohistochemistry and other assays because of the reduced non-specific binding of antibodies to Fc receptors. Antibody fragments without an Fc region have the advantage of being able to reduce non-specific binding. The anti-influenza neuraminidase antibody NC10 is a ScFv that is widely used in diagnosis. The anti-epithelial cell adhesion molecule Ep-CAM antibody MOC-31 is a ScFv for cancer therapy. Bispecific antibodies, trispecific antibodies and tetraspecific antibodies have potential applications in radioimmunotherapy and in vivo imaging diagnosis.
Although various antibody fragments have certain advantages, they are generally not used in experiments. Of the 38,430 articles surveyed by Bangwang in March 2016, only a few articles were related to the application of antibody Fab fragments. The Roche anti-digoxigenin Fab fragment was diluted 1:1000 or 1:2000 in in situ hybridization experiments. The results showed that the major proximal limb subdivision depends on the diffusible signal, and the cilia occurs by cis-regulation of evolutionary assembly. Elemental regulation, the evolution of the simulated wing pattern in butterflies can be regulated by the optrix gene. They are also used for protein folding analysis to study the folding process of individual calmodulin molecules by single-molecule force spectroscopy. Roche anti-digoxigenin antibody is produced in sheep and produced by papain digestion. The Roche anti-fluorescein alkaline phosphatase Fab fragment was used to perform Southern blotting to study the function of topoisomerase II. Recent examples of Roche anti-digoxigenin or anti-fluorescein Fab reagents include expression patterns describing the expression of connexin 35b in neuronal expression, and methods for discussing apoptotic cell death in Drosophila embryos, ovaries, and cultured cell lines, To test whether synaptic GluA2 concentration can regulate protein trafficking or local translation, study the relationship between human cortical formation and impaired acoustic signaling, study the mechanism of clock gene expression traveling wave during development, and study TRF2 and laminin How the interaction between A/C regulates chromosome structure, describes a method for examining the developmental pathways that link specific subtypes of mouse neurons, and other applications.
A covalently bound anti-rabbit IgG Fab fragment from Alexa 546 from Invitrogen was used in immunohistochemistry to study the role of sFLT-1 in maintaining avascular photoreceptor layer in a mouse model. The company's Alexa Fluor 488 rabbit anti-goat IgG (H+L) (Fab') 2 fragment was used in immunohistochemistry to study the mechanism of tip junction regeneration in auditory hair cells.
Fc fragment receptor
The Fc receptor (FcR) is a molecule expressed mainly on/in innate immune cells that recognizes and binds to the Fc domain of an antibody, thereby providing them with a cellular system to elicit an immune response. The multiple functions of FcR reflect the broad protection or regulation of antibodies, including mediation of targeting substrates for neutralization and clearance, and adaptive immunity. The biological function of FcR is regulated by an immunoreceptor tyrosine-based activation motif (ITAM) and an immunoreceptor tyrosine-based inhibition motif (ITIM) as receptor interfaces for activation and inhibition of signaling pathways, respectively. . Thus, signaling by ITAMs can trigger cell activation, phagocytosis and endocytosis, while signaling by ITIMs has an inhibitory effect on cell activation. A description of the FcR of all classes of immunoglobulins is available, some of which are discussed below.
IgG receptor
This family includes FcγRI, FcγRII, FcγRIII and subtypes thereof. They are responsible for antibody-dependent cell-mediated cytotoxicity (ADCC) and antibody-dependent cell-mediated phagocytosis (ACDP).
Another IgG-binding receptor is the neonatal Fc receptor (FcRn), which is involved in the transfer of passive humoral immunity from the mother to the fetus. FcRn also protects IgG from degradation in vivo, which is why they have a long half-life in serum. The Fc-FcRn interaction is promoted by changes in the Fc region, which leads to the development of better therapeutic antibodies.
IgE receptor
They include a high affinity FcRI capable of binding to monomeric IgE and a low affinity C-type lectin FcRII capable of preferentially interacting with the IgE complex. FcRI mediates immediate hypersensitivity responses to many allergic reactions by stimulating cell degranulation and releasing a range of inflammatory mediators on mast cells and basophils. FcRII can exist in both membrane-bound forms for the delivery of down-regulated IgE synthesis and in the presence of soluble fragments to produce an up-regulation effect. Its role in the endocytic process of IgE allergen complexes in human airways and intestinal epithelial cells is being actively studied and may be a potential target for the treatment of allergic airway inflammation caused by food allergies.
IgA receptor
FcRI is the only member of this type and is expressed only in bone marrow lineage cells. It plays a role in pro-inflammatory and anti-inflammatory responses depending on the IgA binding state. Although secretory IgA (SIgA) binding to mucosal sites has anti-inflammatory effects, including prevention of pathogen invasion, binding of serum IgA leads to an inflammatory response. FcRI also regulates neutrophil viability based on the inflammatory microenvironment.
TRIM21
TRIM21 shows a very broad range of antibody specificities and can therefore be distinguished from other FcRs. It can bind IgG, IgM and IgA. In addition, it is expressed in most cells that produce tissue. TRIM2 is involved in antibody-mediated viral replication interference by targeting cytosolic virus-antibody complexes for proteasomal degradation.
Binding of the Fc domain to FcR may have negative effects in monoclonal antibody-based assays such as immunohistochemistry (IHC), flow cytometry (FACS), and chromatin immunoprecipitation (ChIP). Non-specific binding to FcR may introduce background noise, resulting in false positives. Solutions to this problem include the use of an isotype control for gating, serum to compete extensively for non-specifically binding receptors, or purified IgG to specifically block Fc receptors . Innovex's Fc receptor blocker NB309 can be used to block paraffin or cryosections in IHC or IC experiments. BD Biosciences 553142 can be used for flow cytometry.
Other services:
No comments:
Post a Comment